BioCentury
ARTICLE | Clinical News

OP-1 morphogenic protein: CBMI's partner completed patient accrual in its pivotal trial

January 15, 1996 8:00 AM UTC

Autograft requires two surgical procedures, to remove bone chips from a patient's hip and place them into the defect site to stimulate new bone growth. OP-1 requires a single surgical procedure.

The trial has a nine-month followup, with a 1997 PMA submission possible. ...